Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis

por Zhang, Ningning, Ouyang, Yushu, Chang, Jianlan, Liu, Ping, Tian, Xiangyang, Yu, Junyan
Publicado 2020

MicroRNA-429 acts as a tumor suppressor in colorectal cancer by targeting high mobility group box 3

por Tian, Xiangyang, Chang, Jianlan, Zhang, Ningning, Wu, Shouxin, Liu, Huimin, Yu, Junyan
Publicado 2021

Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma

por Zhao, Jian, Lei, Junmei, Yu, Junyan, Zhang, Chengyan, Song, Xuefeng, Zhang, Ninggang, Wang, Yusheng, Zhang, Suxiang
Publicado 2019

The effect of downregulation of Stathmin gene on biological behaviors of U373 and U87-MG glioblastoma cells

por Liu, Ping, Yu, Junyan, Tian, Xiangyang, Chang, Jianlan, Zhang, Ying, Zhang, Rong, Zhang, Ningning, Huang, Ranxing, Li, Lulu, Qiao, Xianli, Guo, Hongliang
Publicado 2018

Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastri...

por Wang, Xiang, Zhong, Diansheng, Zhang, Junping, Du, Nan, Ren, Yuchuan, Gao, Jinghua, Liu, Likun, Yu, Junyan, Li, Xiaomei, Ma, Liwen, Zang, Aimin, Yang, Mudan, Zhang, Yan, Guo, Jun, Liu, Zheng, Fu, Zhanzhao, Jia, Junmei, Diao, Jianfeng, Fan, Zaiwen, Song, Xiang, Li, Guozhong, Wang, Huaqing, Bai, Chunmei, Guan, Mei, Ren, Xiubao, Zhang, Ruixing
Publicado 2022

An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)

por Wang, Xiang, Zhang, Ruixing, Du, Nan, Yang, Mudan, Zang, Aimin, Liu, Likun, Yu, Junyan, Gao, Jinghua, Zhang, Junping, Fu, Zhanzhao, Ren, Yuchuan, Ma, Liwen, Guo, Jun, Li, Qingshan, Li, Xiaomei, Fan, Zaiwen, Song, Xiang, Liu, Zheng, Zhang, Yan, Li, Guozhong, Yu, Zhonghe, Diao, Jianfeng, Jia, Junmei, Liang, Feng, Wang, Huaqing, Sun, Junzhong, Gao, Yunge, Yang, Ping, Bai, Chunmei, Ren, Xiubao, Zhong, Diansheng
Publicado 2020

On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial

por Jiang, Tao, Chen, Jianhua, Xu, Xingxiang, Cheng, Ying, Chen, Gongyan, Pan, Yueyin, Fang, Yong, Wang, Qiming, Huang, Yunchao, Yao, Wenxiu, Wang, Rui, Li, Xingya, Zhang, Wei, Zhang, Yanjun, Hu, Sheng, Guo, Renhua, Shi, Jianhua, Wang, Zhiwu, Cao, Peiguo, Wang, Donglin, Fang, Jian, Luo, Hui, Geng, Yi, Xing, Chunyan, Lv, Dongqing, Zhang, Yiping, Yu, Junyan, Cang, Shundong, Zhang, Yaxi, Zhang, Jiao, Yang, Zeyu, Shi, Wei, Zou, Jianjun, Zhou, Caicun, Ren, Shengxiang
Publicado 2022